Proof-of-concept Study Evaluating Subcutaneous Amlitelimab in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
Clinical trial NCT06118099 · TERMINATED
Trial details
- NCT number
- NCT06118099
- Sponsor
- Sanofi
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-01
- Primary completion
- 2025-02-06
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.